New asthma drug tested in kids: could fasenra help?
NCT ID NCT06427876
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how safe and effective Fasenra (benralizumab) is for children aged 6 to 14 with severe asthma that isn't controlled by other treatments. Researchers will track side effects and measure lung function and asthma control in 40 children over time. The goal is to see how the drug works in real-world use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fasenra (benralizumab) injection
What this could lead to
If successful, this study could confirm that Fasenra is safe and effective for children with severe asthma, offering a new treatment option.
What could go wrong
This is an observational study with only 40 children, so results may not apply to all patients. Side effects like serious infections are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIAL ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Aichi, Japan
-
Research Site
Chiba, Japan
-
Research Site
Hiroshima, Japan
-
Research Site
Hokkaido, Japan
-
Research Site
Hyōgo, Japan
-
Research Site
Ibaraki, Japan
-
Research Site
Kumamoto, Japan
-
Research Site
Mie, Japan
-
Research Site
Okayama, Japan
-
Research Site
Osaka, Japan
-
Research Site
Saitama, Japan